| 摘要 |
<p>The invention provides a crystalline hydrochloride salt of <i>(S)</i>-3-[<i>(S)</i>-l-(4- chlorophenoxy)-2-methylpropyl]pyrrolidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases, (formula).</p> |
